95 related articles for article (PubMed ID: 6821873)
1. Stage III nodular lymphomas. Preliminary results of a combined chemotherapy/radiotherapy program.
Flippin T; McLaughlin P; Conrad FG; Fuller LM; Velasquez WS; Butler JJ; Shullenberger CC
Cancer; 1983 Mar; 51(6):987-93. PubMed ID: 6821873
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
3. Stages IE and IIE non-Hodgkin's lymphomas of the stomach. Comparison of treatment modalities.
Maor MH; Maddux B; Osborne BM; Fuller LM; Sullivan JA; Nelson RS; Martin RG; Libshitz HI; Velasquez WS; Bennett RW
Cancer; 1984 Dec; 54(11):2330-7. PubMed ID: 6208989
[TBL] [Abstract][Full Text] [Related]
4. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
Maor MH; Velasquez WS; Fuller LM; Silvermintz KB
J Clin Oncol; 1990 Feb; 8(2):266-71. PubMed ID: 1688927
[TBL] [Abstract][Full Text] [Related]
5. Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas.
Velasquez W; Fuller LM; Oh KK; Hagemeister FB; Sullivan JA; Manning JT; Shullenberger CC
Cancer; 1984 Apr; 53(7):1478-83. PubMed ID: 6199100
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
7. Team approach to management of non-Hodgkin's lymphomas: past and present.
Fuller LM; Gamble JF; Butler JJ; Sinkovics JG; Wallace S; Martin RG; Gehan EA; Shullenberger CC
Cancer Treat Rep; 1977 Sep; 61(6):1137-48. PubMed ID: 71210
[TBL] [Abstract][Full Text] [Related]
8. Laparotomy staged I and II non-Hodgkin's lymphomas: preliminary results of radiotherapy and adjunctive chemotherapy.
Toonkel LM; Fuller LM; Gamble JF; Butler JJ; Martin RG; Shullenberger CC
Cancer; 1980 Jan; 45(2):249-60. PubMed ID: 6766082
[TBL] [Abstract][Full Text] [Related]
9. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
Lee R; Cabanillas F; Bodey GP; Freireich EJ
J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
Miller TP; Dahlberg S; Cassady JR; Adelstein DJ; Spier CM; Grogan TM; LeBlanc M; Carlin S; Chase E; Fisher RI
N Engl J Med; 1998 Jul; 339(1):21-6. PubMed ID: 9647875
[TBL] [Abstract][Full Text] [Related]
12. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
13. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
14. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
[TBL] [Abstract][Full Text] [Related]
15. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
Fuller LM; Krasin MJ; Velasquez WS; Allen PK; McLaughlin P; Rodriguez MA; Hagemeister FB; Swan F; Cabanillas F; Palmer JL
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):3-11. PubMed ID: 7527799
[TBL] [Abstract][Full Text] [Related]
16. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
19. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Pfreundschuh M; Schubert J; Ziepert M; Schmits R; Mohren M; Lengfelder E; Reiser M; Nickenig C; Clemens M; Peter N; Bokemeyer C; Eimermacher H; Ho A; Hoffmann M; Mertelsmann R; Trümper L; Balleisen L; Liersch R; Metzner B; Hartmann F; Glass B; Poeschel V; Schmitz N; Ruebe C; Feller AC; Loeffler M;
Lancet Oncol; 2008 Feb; 9(2):105-16. PubMed ID: 18226581
[TBL] [Abstract][Full Text] [Related]
20. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
Armitage JO; Dick FR; Corder MP; Garneau SC; Platz CE; Slymen DJ
Cancer; 1982 Nov; 50(9):1695-702. PubMed ID: 6749279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
